Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

High Dimension Characterization of Autologous Hematopoietic Stem Cell Products

FY 2022-23

Summary
Hematopoietic stem cells (HSCs) have the ability to differentiate into all blood cell lineages. These cells are used for an autologous HSC transplant graft (HSCT; also known as an autograft) and are infused back into the patients following intensive chemotherapy. The autograft samples will be stained for mass cytometry and the data obtained will be used to identify and quantify immune cells, including T cells, NK cells, and M-MDSCs subsets, activation, and exhaustion phenotypes present within the graft. Manual gating and dimensionality reduction (e.g. t-SNE) will be applied as biased and unbiased data analysis strategies respectively, which will allow for visualization of many cell populations and their relationship to other cells within the graft. I am comparing samples from cancer patients to healthy donor control samples to identify any differences or similarities in key immune cell populations. I hypothesize that grafts rich in immune effector cell populations, and which contain fewer immune regulatory cells (MDSC, Treg, etc.), will be associated with a more profound anti-tumor activity early post-transplant. My work thus far has established the panel of labeled probes as well as an analysis plan for the quantification of immune cell subsets. This independent project is incorporated into a larger study that involves monitoring the recovery of the immune system post HSCT and the clinical outcome of the patients including major transplant toxicities, relapse and survival. Understanding the functional potential of the immune cell populations present within the autografts will be a beneficial contribution to HSCT and will allow clinicians to design graft and post-transplant strategies that will optimize survival of the patients post-transplant.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486390
Name
geiger cora
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
High Dimension Characterization of Autologous Hematopoietic Stem Cell Products
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autograft; Hematopoietic Stem Cells; Immunological Characterization; Immunology; M-Mdsc; Mass Cytometry; Nk Cells; Oncology; Stem Cell Transplant; T Cells
Abstract
Hematopoietic stem cells (HSCs) have the ability to differentiate into all blood cell lineages. These cells are used for an autologous HSC transplant graft (HSCT; also known as an autograft) and are infused back into the patients following intensive chemotherapy. The autograft samples will be stained for mass cytometry and the data obtained will be used to identify and quantify immune cells, including T cells, NK cells, and M-MDSCs subsets, activation, and exhaustion phenotypes present within the graft. Manual gating and dimensionality reduction (e.g. t-SNE) will be applied as biased and unbiased data analysis strategies respectively, which will allow for visualization of many cell populations and their relationship to other cells within the graft. I am comparing samples from cancer patients to healthy donor control samples to identify any differences or similarities in key immune cell populations. I hypothesize that grafts rich in immune effector cell populations, and which contain fewer immune regulatory cells (MDSC, Treg, etc.), will be associated with a more profound anti-tumor activity early post-transplant. My work thus far has established the panel of labeled probes as well as an analysis plan for the quantification of immune cell subsets. This independent project is incorporated into a larger study that involves monitoring the recovery of the immune system post HSCT and the clinical outcome of the patients including major transplant toxicities, relapse and survival. Understanding the functional potential of the immune cell populations present within the autografts will be a beneficial contribution to HSCT and will allow clinicians to design graft and post-transplant strategies that will optimize survival of the patients post-transplant.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
geiger, cora
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~